novo glp-1 drug Nordisk's oral didn't work on Alzheimer's as hoped, but don't call it a failure Novo Nordisk CEO explains why
Description
p = 0.18
Inoue, T
The effects of GLP-1 RAs on gastrointestinal motility have important clinical implications, including possible increased periprocedural aspiration risk and potential challenges with medication adherence and tolerability
If my back is on this track right now, theres no way." Fox News Digitals Stephanie Giang-Paunon contributed to this report.
But, this side effect can be avoided by following a few best practices before, during and after the injections
95% CI, -0.82% to -0.13%) while maintaining stable kidney function
